COVID-19 rapid test 84000 series

proteinfor antigensSARS-COV-2

The CE certified AESKU.RAPID SARS-CoV-2 Rapid Test is based on immunochromatographic polymer technology combined with the sandwich principle for the qualitative detection of the nucleocapsid protein antigen in human nasal swab specimens. The specimen is placed in the test device's specimen well with colored polymer-labeled monoclonal SARS-CoV-2 antibody 1 and mixed along the nitrocellulose membrane chromatographed. If SARS-CoV-2 antigens are present in the sample, they bind to the SARS-CoV-2 antibody 1.The mixture then binds to the immobilized SARS-CoV-2 antibody 2 on the nitrocellulose membrane. The resulting complex of antibody 1, antigen, and antibody 2 forms the colored test line. The test device's control line is coated with secondary antibodies, which, under normal test procedure, a colored strip is drawn. Product Highlights Antigen rapid test for the direct detection of SARS-CoV-2 NP antigen Lateral-Flow principle based Test material: minimally invasive nasal swab (2.5 cm depth) Detection limit of 50 TCID50/ml No cross-reactivity The rapid antigen test is stable for up to 18 months at 4 - 30°C Test performance at room temperature (15 - 30°C) Each test individually in a sealed foil pouch Pack sizes:5 Tests, including consumables or 20 Tests, including consumables CE certified T